A committee of the European Medicines Agency (EMA) is recommending the refusal of marketing authorization for Nouryant (istradefylline) — approved as Nourianz in the U.S. — as a medication for treating off episodes in Parkinson’s disease in the EU. In its opinion, the Committee for Medicinal Products for Human…

Living with Parkinson’s disease (PD) has been a curse and a blessing. The curse is a progressive chronic illness, and the blessing is being able to write creatively about the experience in a way that helps others. Writing for Parkinson’s News Today provides worthiness, pleasure, and self-expression for me. It’s…

Blood levels of various fat molecules — known as the lipid profile — in people with familial Parkinson’s disease caused by mutations in the GBA gene differ from those seen in people with sporadic Parkinson’s and healthy individuals, a study reported. These findings suggested that problems with lipid metabolism…

Digital health technology, which spans phone apps to telemedicine, is advancing Parkinson’s disease research and clinical care, according to different review studies. “Digital health technology is an important and promising field that is beginning to make a real tangible impact on persons with [Parkinson’s disease],” Anat Mirelman, PhD, a…

Receiving a Parkinson’s diagnosis immediately prompts a cascade of questions encompassing all aspects of life, including career choices. This can be especially challenging with young-onset Parkinson’s disease. What will I look like? Will I be able to care for myself and my family? Should I keep my…

Virtual reality video gaming was helpful and useable as an exercise tool, and demonstrated positive patient satisfaction with no adverse effects among four people with mild to moderate Parkinson’s disease, a case study reported. While previous studies have found limitations with using video games among “more fragile groups,” such…